Tomasz Blicharski Lubelskie Centrum Diagnostyczne
- Address
- lock Available on a paid plan
Skin and Connective Tissue Diseases
At Tomasz Blicharski Lubelskie Centrum Diagnostyczne, clinical research is focused on skin and connective tissue diseases, with a clear emphasis on atopic dermatitis. The studies are designed to evaluate a potential new therapy and better understand its impact on people living with moderate to severe symptoms.
- Research centered on atopic dermatitis and related dermatologic care
- Trials aimed at testing the clinical effectiveness of a new treatment approach
- Work that supports improved management of inflammatory skin disease
This site contributes to dermatology research by helping assess whether an investigational treatment can offer meaningful benefit for patients with persistent skin inflammation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Anaptysbio Inc.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Anaptysbio Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Tomasz Blicharski Lubelskie Centrum Diagnostyczne
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Omecamtiv Mecarbil in Patients with Heart Failure and Severely Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial | Cytokinetics Inc. | Phase III | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anb032 | 2 | Unknown | 2024-04-10 | 2024-04-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.